E-LIB Suche - Ergebnisse für: Yoshito Komatsu

1

Plain language summary of the FOENIX-CCA2 study: futibatini..:

Goyal, Lipika ; Meric-Bernstam, Funda ; Hollebecque, Antoine...
Future Oncology. , 2024

Link: https://doi.org/10.1080/..

2

Large-scale, prospective observational study of regorafenib..:

Komatsu, Yoshito ; Muro, Kei ; Chosa, Masayuki...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

English version of Japanese Clinical Practice Guidelines 20..:

Hirota, Seiichi ; Tateishi, Ukihide ; Nakamoto, Yuji...
International Journal of Clinical Oncology. 29 (2024) 6 - p. 647-680 , 2024

Link: https://doi.org/10.1007/..

4

CA125 Kinetics as a Potential Biomarker for Peritoneal Meta..:

Ueda, Akira ; Yuki, Satoshi ; Ando, Takayuki...
Cancers. 16 (2024) 5 - p. 871 , 2024

Link: https://doi.org/10.3390/..

5

Safety and Efficacy of Encorafenib, Binimetinib, and Cetuxi..:

Kotani, Daisuke ; Takashima, Atsuo ; Kato, Takeshi...
Clinical Colorectal Cancer. 23 (2024) 2 - p. 174-182.e6 , 2024

Link: https://doi.org/10.1016/..

6

Impact of preexisting proteinuria on the development of reg..:

Saito, Yoshitaka ; Takekuma, Yoh ; Komatsu, Yoshito.
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

7

QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFO..:

Bando, Hideaki ; Kotani, Daisuke ; Satake, Hironaga...
Med. , 2024

Link: https://doi.org/10.1016/..

8

Phase II trial of niraparib forBRCA-mutated biliary tract, ..:

Kawamoto, Yasuyuki ; Morizane, Chigusa ; Komatsu, Yoshito...
Future Oncology. , 2024

Link: https://doi.org/10.2217/..

9

Chipping analysis and prediction in gear skiving process us..:

Ren, Zongwei ; Fang, Zhenglong ; Arakane, Takuhiro...
Mechanical Systems and Signal Processing. 211 (2024) - p. 111169 , 2024

Link: https://doi.org/10.1016/..

10

Doublet chemotherapy, triplet chemotherapy, or doublet chem..:

Kato, Ken ; Machida, Ryunosuke ; Ito, Yoshinori...
The Lancet. , 2024

Link: https://doi.org/10.1016/..

11

Evaluation of the risk factors for the failure of a single ..:

Watanabe, Takuya ; Saito, Yoshitaka ; Takekuma, Yoh...
Int. Journal of Clinical Pharmacology and Therapeutics. 62 (2024) 5 - p. 213-221 , 2024

Link: https://doi.org/10.5414/..

12

Baseline ctDNA gene alterations as a biomarker of survival ..:

Shitara, Kohei ; Muro, Kei ; Watanabe, Jun...
Nature Medicine. 30 (2024) 3 - p. 730-739 , 2024

Link: https://doi.org/10.1038/..

13

Severe hypertension development significantly improves prog..:

Saito, Yoshitaka ; Takekuma, Yoh ; Komatsu, Yoshito.
International Journal of Clinical Oncology. 28 (2023) 9 - p. 1183-1190 , 2023

Link: https://doi.org/10.1007/..

14

Assessment for the timing of comprehensive genomic profilin..:

Hagio, Kanako ; Kikuchi, Junko ; Takada, Kohichi...
Cancer Science. 114 (2023) 8 - p. 3385-3395 , 2023

Link: https://doi.org/10.1111/..

15

Phase I Study of the Liposomal Formulation of Eribulin (E73..:

Shitara, Kohei ; Hirao, Motohiro ; Iwasa, Satoru...
Clinical Cancer Research. 29 (2023) 8 - p. 1460-1467 , 2023

Link: https://doi.org/10.1158/..